Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C genotypes: current trends and future implications

N N Zein1, D H Persing

  • 1Division of Gastroenterology and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.

Mayo Clinic Proceedings
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De Novo Autoimmune Hepatitis Following Liver Transplantation.

Transplantation proceedings·2018
Same author

Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.

Transplantation proceedings·2016
Same author

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation.

International journal of organ transplantation medicine·2016
Same author

Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir.

International journal of organ transplantation medicine·2015
Same author

Monitoring serial CD4⁺ T-cell function after liver transplantation can be used to predict hepatocellular carcinoma recurrence.

Transplantation proceedings·2015
Same author

IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens.

International journal of organ transplantation medicine·2014

Understanding hepatitis C virus (HCV) genotypes is crucial for patient outcomes. Identifying specific HCV genotypes can guide effective interferon treatment strategies for chronic liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • Different HCV genotypes exhibit varying impacts on liver disease progression and treatment response.

Purpose of the Study:

  • To review the geographic distribution of HCV genotypes.
  • To understand the association between HCV genotypes, liver disease activity, and treatment outcomes.

Main Methods:

  • Literature review of the relevant medical research.
  • Analysis of recent findings on chronic HCV infection and genotype importance.

Main Results:

  • HCV genotypes 1a and 1b are prevalent in the United States.
  • HCV genotype 1b is linked to more severe liver disease and increased hepatocellular carcinoma risk.

Related Experiment Videos

  • HCV genotype 2b shows higher sensitivity to interferon therapy, while genotype 1b is least sensitive.

    • Conclusions:

    • Identifying the infecting HCV genotype can aid clinical decision-making.
    • Genotype information may help select patients who will benefit most from interferon treatment.